U.S loans $1.1 billion to Ginkgo Bioworks for pandemic effort - Reuters

5:10am PST - November 25th, 2020    moderna stock - Reuters

The U.S. government has agreed to loan privately-held biotechnology firm Ginkgo Bioworks $1.1 billion for COVID-19 testing and the production of raw materials for therapies that may help address future pandemics.